A detailed history of Semanteon Capital Management, LP transactions in Innoviva, Inc. stock. As of the latest transaction made, Semanteon Capital Management, LP holds 47,247 shares of INVA stock, worth $941,160. This represents 0.62% of its overall portfolio holdings.

Number of Shares
47,247
Previous 25,066 88.49%
Holding current value
$941,160
Previous $411 Million 121.94%
% of portfolio
0.62%
Previous 0.29%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$16.33 - $20.04 $362,215 - $444,507
22,181 Added 88.49%
47,247 $912 Million
Q2 2024

Jul 30, 2024

BUY
$14.4 - $16.4 $360,950 - $411,082
25,066 New
25,066 $411 Million

Others Institutions Holding INVA

About Innoviva, Inc.


  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.39B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Semanteon Capital Management, LP Portfolio

Follow Semanteon Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Semanteon Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Semanteon Capital Management, LP with notifications on news.